The effect of cardiovascular credentialed pharmacists on process measures and outcomes in myocardial infarction and heart failure

Pharmacotherapy

Volumn 34, Issue 8, 2014, Pages 803-808

  Dorsch, Michael P ^a   Lose, Jennifer M ^b   DiDomenico, Robert J ^c  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

acute myocardial infarction; congestive heart failure; credentialing; epidemiology; performance measures; pharmacist management

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACCREDITATION; ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHARMACIST; RETROSPECTIVE STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITAL; HOSPITAL PHARMACY; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; ORGANIZATION AND MANAGEMENT; STANDARDS; STATISTICS AND NUMERICAL DATA;

CASE-CONTROL STUDIES; CREDENTIALING; CROSS-SECTIONAL STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROCESS ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES;

EID: 84905968472     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1444     Document Type: Article

References (16)

1. American Board of Medical Specialties. Available from http://www.abms.org. Accessed July 27, 2011.
2. Board of Pharmacy Specialties. Available from www.bpsweb.org. Accessed July 27, 2011.
3. American College of Clinical Pharmacy. ACCP position statement: board certification of pharmacist specialists. Pharmacotherapy 2011; 31: 1146-9.
4. Blair MM, Freitag RT, Keller DL, et al. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy 2009; 29: 3e-13e.
5. Spinler SA, Bosso J, Hak L, et al. Report of the taskforce concerning board certification requirements for pharmacy practice faculty. Am J Pharm Educ 1997; 61: 213-6.
6. Pradel FG, Palumbo FB, Flowers L, Mullins CD, Haines ST, Roffman DS,. White paper: value of specialty certification in pharmacy. J Am Pharm Assoc 2004; 44: 612-20.
7. American Society of Health-System Pharmacists Web site. Available from http://www.ashp.org. Accessed June 20, 2012.
8. White C, Chow M,. Cost impact and clinical benefits of focused rounding in the cardiovascular intensive care unit. Hosp Pharm 1998; 33: 419-23.
9. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL,. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955-64.
10. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT,. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008; 168: 687-94.
11. Bond CA, Raehl CL, Patry R,. Evidence-based core clinical pharmacy services in United States hospitals in 2020: services and staffing. Pharmacotherapy 2004; 24: 427-40.
12. Maeda JL,. Evidence-based heart failure performance measures and clinical outcomes: a systematic review. J Card Fail 2010; 16: 411-8.
13. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007; 297: 61-70.
14. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA 2006; 296: 72-8.
15. Chen J, Rathore SS, Wang Y, Radford MJ, Krumholz HM,. Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med 2006; 21: 238-44.
16. Curtis JP, Luebbert JJ, Wang Y, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009; 301: 1661-70.